Updated:
Sotera Health
Sotera Health owns Sterigenics, Nordion, and Nelson Labs — an integrated platform serving more than 5,000 medtech and pharma customers across over 50 countries.
Sotera Health
Learn how Sotera Health provides integrated health and sterilization services with the scientific expertise of Nelson Labs, Nordion and Sterigenics
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Broadview Heights
Corporate office
9100 South Hills Blvd, Suite 300, Broadview Heights, OH 44147, United States
Additional offices
Oak Brook, IL, United States (Sterigenics) · Salt Lake City, UT, United States (Nelson Labs) · Ottawa, ON, Canada (Nordion)
Sector focus
Frequently asked questions
What is the relationship among Sotera Health, Sterigenics, Nordion, and Nelson Labs?
Sotera Health Company is the publicly traded corporate parent. Sterigenics provides outsourced terminal sterilization and irradiation services, Nordion supplies Cobalt-60 and gamma technologies, and Nelson Labs performs microbiological and analytical chemistry testing and advisory services. The three subsidiaries operate as integrated business units rather than portfolio companies of an investment fund.
Is Sotera Health an investment firm or an operating company?
It is an operating company structured as a publicly traded corporation (Nasdaq: SHC). It does not manage third-party capital pools or report assets under management. It directly owns and operates sterilization facilities, isotope logistics, and laboratory networks.
How does Sotera Health generate revenue?
Revenue comes from fees for sterilization services per unit or per cycle (Sterigenics), sales of Cobalt-60 and related isotope products (Nordion), and per-test or retainer-based laboratory testing and regulatory advisory engagements (Nelson Labs). The diversified revenue base is tied to healthcare manufacturing volumes rather than investment returns.
What is the regulatory exposure for Sotera Health's sterilization operations?
The company operates under FDA, EPA, and international health-authority oversight for its ethylene oxide and gamma irradiation facilities. Emissions control, worker safety, and community health concerns have led to litigation and regulatory scrutiny, most notably the ethylene oxide lawsuits in Illinois that the company settled in October 2023.
Does Sotera Health allocate capital to external funds or pursue minority investments?
No. Sotera Health's capital allocation focuses on maintaining and expanding owned sterilization and lab-testing infrastructure. It does not operate as a fund-of-funds, a direct-investment platform for external LPs, or a minority-stake portfolio manager.
What scale does Sotera Health's infrastructure represent?
The company serves approximately 5,000 customers across over 50 countries. Sterigenics alone operates 49 facilities worldwide, Nelson Labs runs 12, and Nordion supplies products to more than 40 countries. The platform supports the sterilization and testing of products used by more than 190 million patients and practitioners annually.
Who owned Sotera Health before it went public?
Prior to its November 2020 IPO on Nasdaq, Sotera Health was owned by private equity sponsors Warburg Pincus and GTCR, which had acquired and combined the Sterigenics, Nordion, and Nelson Labs businesses over the preceding decade.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: